Evidence map›Paper›PMID 25303643›Full record

ArticlePloS one2014

Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion.

Erin J Debruin, Michael R Hughes, Christina Sina, Alex Lu, Alex Liu, Jessica Cait, Zhiqi Jian, Martin Lopez, Bernard Lo, Thomas Abraham and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Gene-Specific Endothelial Programs Drive AVM Pathogenesis inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Lung cancer stem cells-characteristics, phenotype.Translational lung cancer research · 2016
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
    Liu, Alex [corrected to Lu, Alex]
5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Erin J DebruinThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Michael R HughesThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Christina SinaThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Alex Lu
Alex LiuThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Jessica CaitThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Zhiqi JianThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Martin LopezThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Bernard LoThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
Thomas AbrahamUBC James Hogg Research Centre, Institute for Heart + Lung Health, Vancouver, BC, Canada; Penn State College of Medicine, Penn State University, Hershey, Pennsylvania, United States of America.
Kelly M McNagnyThe Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada.
University of British Columbia · CABC Research (Canada) · CA

Funding

Canadian Institutes of Health Research MOP-84545
6 · The paper itself

Abstract

Despite the widespread use of CD34-family sialomucins (CD34, podocalyxin and endoglycan) as vascular endothelial cell markers, there is remarkably little known of their vascular function. Podocalyxin (gene name Podxl), in particular, has been difficult to study in adult vasculature as germ-line deletion of podocalyxin in mice leads to kidney malformations and perinatal death. We generated mice that conditionally delete podocalyxin in vascular endothelial cells (Podxl(ΔEC) mice) to study the homeostatic role of podocalyxin in adult mouse vessels. Although Podxl(ΔEC) adult mice are viable, their lungs display increased lung volume and changes to the matrix composition. Intriguingly, this was associated with increased basal and inflammation-induced pulmonary vascular permeability. To further investigate the etiology of these defects, we isolated mouse pulmonary endothelial cells. Podxl(ΔEC) endothelial cells display mildly enhanced static adhesion to fibronectin but spread normally when plated on fibronectin-coated transwells. In contrast, Podxl(ΔEC) endothelial cells exhibit a severely impaired ability to spread on laminin and, to a lesser extent, collagen I coated transwells. The data suggest that, in endothelial cells, podocalyxin plays a previously unrecognized role in maintaining vascular integrity, likely through orchestrating interactions with extracellular matrix components and basement membranes, and that this influences downstream epithelial architecture.

Indexed as

Capillary PermeabilityAnimalsCell AdhesionCells, CulturedEndothelial CellsGene DeletionLungMiceSialoglycoproteinspodocalyxinSialoglycoproteins

Identifiers

PMID25303643
PMCPMC4193771
OpenAlexW2075855559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.